ISSCR Announces New Policy Director

  • 20 February, 2017

CHICAGO, 20 February 2017 - The ISSCR has named Kaye Meier to be its new Director of Policy. Meier is responsible for directing, planning, and executing policy and advocacy efforts, enabling the society and its members to actively engage in shaping stem cell-related public policy around the world.

“Kaye brings valuable policy experience and deep expertise to our organization,” said ISSCR President Sally Temple. “We look forward to her insights and contributions to issues affecting stem cell research and its translation to the clinic,” she said.

Prior to joining the ISSCR, Meier worked for the United States Senate for 17 years, managing legislative and legal staff and providing counsel to Members of Congress. Most recently she served as Senator Barbara Boxer’s legislative director (2014-2017), overseeing development of legislative and communication strategies on issues such as healthcare, intellectual property rights, consumer protection, and others.

Meier’s earlier work includes 15 years as senior counsel to Senator Carl Levin of Michigan, where she provided counsel and advocated for the “Cure Michigan” stem cell ballot initiative, which passed successfully. On behalf of the senator, she worked with U.S. administration officials, scientists, researchers, and experts in technology to develop policy initiatives and legislation on civil rights, healthcare, patent and copyright issues, appropriations, and ethics, among others.

Meier earned a BA from the Michigan State University and a JD from the California Western School of Law in San Diego, where she served as editor in chief of the law review, and graduated magna cum laude.